Brissot, E. Et Al. 2016. An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party. 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (California, United States Of America).

Brissot, E., Labopin, M., Russo, D., Martin, S., Schmid, C., Glass, B., ... Ram, R.(2016). An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party . 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America

Brissot, Eolia Et Al. "An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party," 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 2016

Brissot, Eolia Et Al. "An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party." 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , California, United States Of America, 2016

Brissot, E. Et Al. (2016) . "An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party." 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , California, United States Of America.

@conferencepaper{conferencepaper, author={Eolia Brissot Et Al. }, title={An Alternative Donor Is a Valid Option Compared to a Matched-Unrelated in Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in CR2: A Report of 841 Patients from the EBMT Acute Leukemia Working Party}, congress name={58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={California}, country={United States Of America}, year={2016}}